Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00431
|
|||||
| Drug Name |
Phenytoin
|
|||||
| Synonyms |
2,4-Imidazolidinedione, 5,5-diphenyl-(9CI); 2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one; 5,5-DIPHENYLHYDANTOIN; 5,5-Diphenyl-2,4-imidazolidinedione; 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-Diphenylhydantoin (IUPAC); 5,5-Diphenylhydantoin (phenytoin); 5,5-Diphenylimidazolidin-2,4-dione; 5,5-Dwufenylohydantoina; 5,5-Dwufenylohydantoina [Polish]; 5,5-diphenylimidazolidine-2,4-dione; Aleviatin; Antisacer; Auranile; CL12003; Causoin; Citrullamon; Citrulliamon; Comital; Comitoina; Component of Mebroin; Convul; D 4007; D4007_SIGMA; DILANTIN-30; DPH (VAN); Danten; Dantinal; Dantoinal; Dantoinal klinos; Dantoine; Denyl; Di-Hydan; Di-Lan; Di-Lan (VAN); Di-Phetine; Didan TDC 250; Didan-tdc-250; Difenilhidantoina; Difenilhidantoina [Spanish]; Difenin; Difetoin; Difhydan; Dihycon; Dihydan toin; Dihydantoin; Dilabid; Dilantin; Dilantin (TN); Dilantin Infatabs (TN); Dilantin Kapseals (TN); Dilantin acid; Dilantin-125; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylhydantoin; Diphenylhydantoin (VAN); Diphenylhydantoine; Diphenylhydantoine [French]; Diphenylhydatanoin; Ditoinate; Ekko; Ekko capsules; Elepsi ndon; Elepsindon; Enkelfel; Epamin; Epanutin; Epanutin (TN); Epasmir (5); Epasmir 5; Epdantoin Simple; Epdantoine simple; Epelin; Epifenyl; Epihydan; Epilan D; Epilan-D; Epilantin; Epinat; Epised; Eptal; Eptoin; Eptoin (TN); Extended Phenytoin Sodium; Fen toin; Fenantoin Mn Pharma; Fenidantoin (s); Fenidantoin s; Fenitoin; Fenitoina; Fenitoina [INN-Spanish]; Fentoin; Fenylepsin; Fenytoin Dak; Fenytoine; Gerot-epilan-D; Hidan; Hidantal; Hidantilo; Hidantina; Hidantina senosian; Hidantina vitoria; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoin, 5,5-diphenyl-(8CI); Hydantoinal; Hydantol; IFLab1_000214; Ictalis simp le; Ictalis simple; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Minetoin; Neos-Hidantoina; Neosidantoina; Novantoina; Novophenytoin; Om hidantoina simple; Om-Hydantoine; Oxylan; PHENYTEK; PHENYTOIN (5,5-DIPHENYLHYDANTOIN); PHENYTOIN SODIUM, EXTENDED; Phanantin; Phanatine; Phenat ine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytek (TN); Phenytex; Phenytoin (JP15/USP/INN); Phenytoin (PHN); Phenytoin AWD; Phenytoin [USAN:INN:BAN:JAN]; Phenytoin-Gerot; Phenytoine; Phenytoine [INN-French]; Phenytoinum; Phenytoinum [INN-Latin]; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Sodium Diphenylhydantoinate; Solantin; Solantoin; Solantyl; Sylantoic;TOIN; Taco sal; Tacosal; Thilophenyl; Toin unicelles; Zentronal; Zentropil
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Seizures following neurosurgery [ICD11: 8A6Z] | Approved | [1] | |||
| Therapeutic Class |
Anticonvulsants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H12N2O2
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
|
|||||
| InChI |
InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)
|
|||||
| InChIKey |
CXOFVDLJLONNDW-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 57-41-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 252.27 | Topological Polar Surface Area | 58.2 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
2.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10527886
, 10589150
, 11111069
, 11335682
, 11353793
, 11360921
, 11363999
, 11366561
, 11369123
, 11371880
, 11374526
, 11377285
, 11461893
, 11485017
, 11489097
, 11490706
, 11492799
, 11494919
, 11532994
, 14847761
, 17389903
, 17404941
, 24278370
, 26068808
, 26753026
, 26753027
, 26753028
, 29220975
, 3136997
, 4284342
, 46508847
, 47588955
, 47736431
, 47736432
, 47795039
, 48168464
, 48184955
, 48243361
, 48413692
, 48416427
, 48422573
, 5171921
, 592179
, 596082
, 74340
, 7847578
, 7980312
, 8151275
, 841957
, 9647
|
|||||
| ChEBI ID |
CHEBI:8107
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP1 | Transporter Info | Multidrug resistance-associated protein 1 | Substrate | [2] | |
| MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [3] | ||
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [4] | ||
| References | ||||||
| 1 | Phenytoin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology. 2010 Jun;58(7):1019-32. | |||||
| 3 | Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats. Epilepsia. 2007 Apr;48(4):631-45. | |||||
| 4 | The transport of antiepileptic drugs by P-glycoprotein. Adv Drug Deliv Rev. 2012 Jul;64(10):930-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.